换一批
换一批Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC).
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);基因扩增(Gene Amplification);基因, erbB-2(Genes, erbB-2);人类(Humans);原位杂交, 荧光(In Situ Hybridization, Fluorescence);肿瘤转移(Neoplasm Metastasis);磷酰化(Phosphorylation);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1016/j.ejca.2006.11.019
PMID
17251007
发布时间
2022-03-18
- 浏览21
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
